共 248 条
[11]
Vaidya AB(2003)Structural features of Malar J 2 5-1078
[12]
Vaidya AB(1995) cytochrome b that may underlie susceptibility to 8-aminoquinolines and hydroxynaphthoquinones J Antimicrob Chemother 36 1073-66
[13]
Mather MW(1996)A mechanism for the synergistic antimalarial action of atovaquone and proguanil Am J Trop Med Hyg 54 62-89
[14]
Kessl JJ(2002)Different mutation patterns of atovaquone resistance to Malar J 1 1-363
[15]
Ha KH(2003) in vitro and in vivo: rapid detection of codon 268 polymorphisms in the cytochrome b as potential in vivo resistance marker Mol Cell Probes 17 85-1546
[16]
Merritt AK(2004)Evaluation of atovaquone in the treatment of patients with uncomplicated Trop Med Int Health 9 361-2281
[17]
Lange BB(2006) malaria Malar J 5 30-2604
[18]
Hill P(2004)Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand J Infect Dis 190 1541-898
[19]
Meunier B(2007)Malarone treatment failure and in vitro confirmation of resistance of Antimicrob Agents Chemother 51 2280-629
[20]
Meshnick SR(2006) isolate from Lagos, Nigeria Microbes Infect 8 2599-409